Senior CMC Specialist, Downstream Processing, Lifecycle Management

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

Genmab is a growing organization, and you will be encouraged and welcomed to bring forth new ideas, discuss concerns, and share feedback with colleagues and management.

Do you want to work as one team? Share knowledge, be curious, ask questions, and learn new things to achieve goals and meet ambitious deadlines? You will be rewarded by focusing on teamwork and achieving outstanding results through and with your team.

You will be part of Late-Stage Manufacturing Development (LSMD), contributing to late-phase development with a clear focus on lifecycle management activities across portfolio projects and preparing CMC packages for regulatory filings in a stimulating international environment. If you can recognize yourself in this description, you might be the next (Senior) CMC Specialist, Downstream Processing, Lifecycle Management, supporting Genmab’s expanding portfolio and continued global growth.

The position is placed in the DSP/DS team within Process Development. Process Development is part of LSMD and is responsible for Upstream, Downstream, and drug linker processes. The function currently consists of 13 people and is expanding. You will report to the DSP/DS Team Lead within Process Development.

The position is based in Copenhagen, Denmark.
Applications are reviewed on an ongoing basis.

With strong drive and engagement, you will join Genmab’s growth journey and contribute with your downstream experience in a lifecycle management context. As the (Senior) Downstream Processing (DSP) subject matter expert (SME) for lifecycle management, you will be responsible for the following:

• DSP activities performed at Genmab’s partnered CMOs and work across project teams to support the CMC Project Manager

• Developing late-stage DSP and DS strategies for ongoing projects

• Act as the primary expert for managing the lifecycle of late-stage biopharmaceutical products, ensuring alignment with regulatory requirements and company standards

• Defining the scope for late-stage DSP and DS development activities with our CMOs and partners according to the latest industry standards and regulatory guidance

• Overseeing DSP and DS activities performed at partnered CMOs, including troubleshooting, process characterization, and process performance qualification

• Preparing and reviewing technical documents, including development/tech transfer/process characterization reports and batch records

• Authoring and reviewing CMC regulatory submission documents

• Working closely with upstream processing, analytical validation, and characterization SMEs to develop and align late-stage development strategies

• Supporting the definition and refinement of required processes for DSP activities

The successful candidate will have the following profile:

• Thorough understanding and overview of downstream processes, with in-depth knowledge of downstream process characterization, risk assessment, and late-stage validation activities

• Experience in leading lifecycle management activities, including process optimization, process comparability, and global post-approval changes

• Preferred experience in antibody drug conjugates (ADCs)

• Preferred experience in designing and evaluating DoE experiments

• Preferred experience with virus clearance study design and evaluation

• Preferred experience in preparing and reviewing relevant filing documentation for regulatory market authorizations

Moreover, you meet the following personal requirements:

• You are focused on achieving goals that are important for the team and the organization

• You have a proactive approach and a desire to continuously develop and find innovative solutions

• In addition, you are well-organized, and can plan, execute, and meet deadlines

• You have the ability to work successfully in a fast-paced environment and with tight timelines

About You

• You are genuinely passionate about our purpose

• You bring precision and excellence to all that you do

• You believe in our rooted-in-science approach to problem-solving

• You are a generous collaborator who can work in teams with a broad spectrum of backgrounds

• You take pride in enabling the best work of others on the team

• You can grapple with the unknown and be innovative

• You have experience working in a fast-growing, dynamic company (or a strong desire to)

• You work hard and are not afraid to have a little fun while you do so!

Locations

Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are crafted as open, community-based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you’re in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).